BioSpace News Archive

Business

Pasithea Therapeutics Announces Results from 2023 Annual Meeting

Pasithea Therapeutics Corp., announced that it held its annual meeting of stockholders on December 19, 2023.

December 19, 2023
·
4 min read
Burning Rock Announces Results of 2023 Annual General Meeting

Burning Rock Biotech Limited announced that all shareholder resolutions proposed at the Company’s 2023 annual general meeting held today were duly passed.

December 19, 2023
·
2 min read
Genetown

Syndax Announces Closing of Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Syndax Pharmaceuticals, Inc. announced the closing of its previously announced underwritten public offering of 12,432,431 shares of its common stock, which includes the exercise in full of the underwriters’ option to purchase 1,621,621 additional shares.

December 19, 2023
·
3 min read
Business

InxMed Enters License Agreement with Escugen to Develop Next-Generation ADCs

InxMed and Escugen announced that InxMed licensed EZWi-Fit® linker-payload platform from Escugen for the development of the next generation tumor-associated antigens targeting ADCs.

December 19, 2023
·
4 min read
Business

Cenna Announces Appointment of David H. Crean to Board of Directors

Cenna Biosciences announced the appointment of David H. Crean to the Cenna Board of Directors effective Dec. 12, 2023.

December 19, 2023
·
3 min read
Genetown

bluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common Stock

bluebird bio, Inc. announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public offering price of $1.50 per share, before deducting underwriting discounts and commissions.

December 19, 2023
·
5 min read